Abametapir

Abametapir (sold as Xeglyze) is a prescription topical lotion approved by the FDA in July 2020 for treating head lice in individuals 6 months and older. It is a metalloproteinase inhibitor that acts as an ovicidal pediculicide, killing both adult lice and eggs in a single 10-minute application. Common side effects include skin irritation, rash, and red scalp